share_log

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $15 Price Target

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $15 Price Target

D. Boral Capital重申对reviva pharmaceuticals的买入评级,维持目标价15美元
Benzinga ·  2024/11/13 18:07  · 评级/大行评级

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $15 price target.

D. Boral Capital 的分析师 Jason Kolbert 维持了 reviva pharmaceuticals (纳斯达克:RVPH) 的 买入评级,并维持 $15 的价格目标。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发